ストックスクリーナーアプリを入手
2.51
2.33%
-0.06
アフターアワーズ：
2.53
0.02
+0.80%
前日終値:
$2.57
開ける：
$2.53
24時間の取引高:
604.90K
Relative Volume:
0.48
時価総額：
$96.54M
収益：
$210.70K
当期純損益:
$-21.37M
株価収益率:
-2.2818
EPS:
-1.1
ネットキャッシュフロー:
$-21.10M
1週間 パフォーマンス:
+1.21%
1か月 パフォーマンス:
+54.94%
6か月 パフォーマンス:
+42.61%
1年 パフォーマンス:
+35.68%
1日の値動き範囲:
$2.4367
$2.55
1週間の範囲:
$2.37
$2.74
52週間の値動き範囲:
$1.41
$4.34
Gain Therapeutics Inc Stock (GANX) Company Profile
Compare GANX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
2.51 | 98.85M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-12-06 | 開始されました | ROTH MKM | Buy |
| 2024-08-14 | 再開されました | Oppenheimer | Outperform |
| 2021-04-12 | 開始されました | BTIG Research | Buy |
| 2021-04-12 | 開始されました | Oppenheimer | Outperform |
Gain Therapeutics Inc (GANX) 最新ニュース
Bearish Setup: What is Gain Therapeutics Incs 5 year growth outlookTrade Analysis Report & AI Powered Market Entry Ideas - baoquankhu1.vn
GANX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will Voyager Therapeutics Inc. stock gain from lower inflationTrade Analysis Report & Daily Oversold Stock Bounce Ideas - mfd.ru
Celldex Therapeutics Opens with a 6.56% Gain, Outpacing S&P 500's 0.69% Increase - Markets Mojo
GANX PE Ratio & Valuation, Is GANX Overvalued - Intellectia AI
Intellia Therapeutics Opens with 6.49% Gain, Outperforming S&P 500's 0.69% Rise - Markets Mojo
Gain Therapeutics to Present Key Clinical Program Updates at Oppenheimer Conference - AD HOC NEWS
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views - Benzinga
Gain Therapeutics, Inc. (NASDAQ:GANX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference - 富途牛牛
What’s the beta of Gain Therapeutics Inc. stock2025 Short Interest & Detailed Earnings Play Alerts - mfd.ru
What’s the analyst consensus on Gain Therapeutics Inc.Weekly Trade Review & Risk Controlled Swing Alerts - mfd.ru
Can Gain Therapeutics Inc. stock double in the next yearBreakout Watch & Weekly High Return Forecasts - mfd.ru
Aug Summary: Is Gain Therapeutics Inc stock a falling knife or bargain buyJuly 2025 Technicals & Growth-Oriented Investment Plans - baoquankhu1.vn
What dividend safety score for Gain Therapeutics Inc. stockWeekly Profit Analysis & High Accuracy Trade Alerts - mfd.ru
Market Fear: Is Gain Therapeutics Inc a strong candidate for buy and holdAnalyst Upgrade & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Gain Therapeutics, Inc. (NASDAQ:GANX) Short Interest Up 19.9% in January - MarketBeat
Published on: 2026-02-16 00:03:51 - mfd.ru
Is Gain Therapeutics Inc. benefiting from innovation trendsJuly 2025 Sentiment & Fast Entry High Yield Stock Tips - mfd.ru
Will Edgewise Therapeutics Inc. stock gain from government policies2025 Fundamental Recap & Reliable Entry Point Trade Alerts - mfd.ru
Insider Trends: Whats the beta of Themes Etf Trust Leverage Shares 2x Long Panw Daily Etf stockPortfolio Gains Report & Safe Entry Trade Signal Reports - baoquankhu1.vn
Aug Wrap: Whats the analyst consensus on Gain Therapeutics IncJobs Report & Risk Managed Investment Signals - baoquankhu1.vn
Will Entrada Therapeutics Inc. stock gain from lower inflationJuly 2025 Patterns & Long-Term Capital Growth Ideas - mfd.ru
GANX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is Gain Therapeutics Inc. vulnerable to short sellersTrade Risk Summary & Real-Time Market Trend Scan - mfd.ru
Can Gain Therapeutics Inc. continue delivering strong returnsJuly 2025 Short Interest & AI Forecasted Entry/Exit Points - mfd.ru
Is Gain Therapeutics Inc. forming bullish engulfing patternsProfit Target & Low Risk High Reward Trade Ideas - mfd.ru
Critical Contrast: Gain Therapeutics (NASDAQ:GANX) and Ionis Pharmaceuticals (NASDAQ:IONS) - Defense World
Gain Therapeutics, Inc Advances Parkinson's Treatment to Phase 2 - TradingView
Treasury Yields: What hedge funds are buying Gain Therapeutics IncMarket Growth Report & Long-Term Safe Return Strategies - baoquankhu1.vn
Can Gain Therapeutics Inc. outperform in the next rallyCPI Data & Safe Swing Trade Setup Alerts - mfd.ru
Smart Money: Is Gain Therapeutics Inc part of any major index2025 Buyback Activity & Risk Controlled Daily Plans - baoquankhu1.vn
Is Pediatrix Medical Group Inc. stock undervalued right nowJuly 2025 Breakouts & Technical Confirmation Alerts - baoquankhu1.vn
Published on: 2026-01-31 20:42:39 - baoquankhu1.vn
Wall Street Recap: Can Gain Therapeutics Inc outperform in the next rallyTrade Performance Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
What CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) 35% Share Price Gain Is Not Telling You - simplywall.st
Gain Therapeutics, Inc. (NASDAQ:GANX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
5 Investigational Therapies That Could Change the Parkinson’s Landscape - BioSpace
Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Bond Watch: Will Atlantica Sustainable Infrastructure plc stock benefit from M AMarket Growth Review & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Aug Final Week: Should I average down on Gain Therapeutics Inc stockNew Guidance & Safe Entry Trade Signal Reports - baoquankhu1.vn
Can Gain Therapeutics Inc. stock attract ESG capital inflowsVolatility Adjusted Trading & Free Stay Informed With Forecasts - Bollywood Helpline
Short Interest in Gain Therapeutics, Inc. (NASDAQ:GANX) Rises By 28.6% - MarketBeat
Aug PreEarnings: Can Gain Therapeutics Inc continue delivering strong returnsJuly 2025 Action & Low Volatility Stock Recommendations - baoquankhu1.vn
Exit Recap: Is Gain Therapeutics Inc attractive for institutional investors2025 Breakouts & Breakdowns & Weekly Watchlist of Top Performers - baoquankhu1.vn
Wall Street Recap: Is Gain Therapeutics Inc trading at a discountWeekly Earnings Recap & Consistent Profit Trading Strategies - baoquankhu1.vn
Pullback Watch: What is Gain Therapeutics Incs 5 year growth outlookTrade Volume Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Movement Recap: Can Gain Therapeutics Inc outperform in the next rallyJuly 2025 Spike Watch & Free Verified High Yield Trade Plans - baoquankhu1.vn
Aug Fed Impact: Whats the beta of Gain Therapeutics Inc stockMarket Activity Recap & Fast Entry and Exit Trade Plans - baoquankhu1.vn
EPS Watch: Whats the beta of Gain Therapeutics Inc stock2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Aug Intraday: What is Gain Therapeutics Incs TAM Total Addressable MarketJuly 2025 Breakouts & Daily Profit Focused Stock Screening - baoquankhu1.vn
Gain Therapeutics Inc (GANX) 財務データ
収益
当期純利益
現金流量
EPS
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):